JPWO2020204173A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020204173A5 JPWO2020204173A5 JP2021512328A JP2021512328A JPWO2020204173A5 JP WO2020204173 A5 JPWO2020204173 A5 JP WO2020204173A5 JP 2021512328 A JP2021512328 A JP 2021512328A JP 2021512328 A JP2021512328 A JP 2021512328A JP WO2020204173 A5 JPWO2020204173 A5 JP WO2020204173A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- acceptable salt
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019072911 | 2019-04-05 | ||
| JP2019072911 | 2019-04-05 | ||
| PCT/JP2020/015364 WO2020204173A1 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバントおよびそれを含有する組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020204173A1 JPWO2020204173A1 (https=) | 2020-10-08 |
| JPWO2020204173A5 true JPWO2020204173A5 (https=) | 2023-04-12 |
| JP7573516B2 JP7573516B2 (ja) | 2024-10-25 |
Family
ID=72668989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512328A Active JP7573516B2 (ja) | 2019-04-05 | 2020-04-03 | 水溶性アジュバントおよびそれを含有する組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220241409A1 (https=) |
| EP (1) | EP3954382A4 (https=) |
| JP (1) | JP7573516B2 (https=) |
| KR (1) | KR20220004030A (https=) |
| CN (1) | CN113905758A (https=) |
| AU (1) | AU2020255935A1 (https=) |
| CA (1) | CA3136066A1 (https=) |
| MX (1) | MX2021012200A (https=) |
| WO (1) | WO2020204173A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020022301A1 (ja) | 2018-07-24 | 2020-01-30 | 日本化薬株式会社 | エポキシ樹脂、エポキシ樹脂組成物、炭素繊維強化複合材料用エポキシ樹脂組成物、プリプレグ、炭素繊維強化複合材料 |
| MX2024001843A (es) * | 2021-08-12 | 2024-05-16 | Int Inst Cancer Immunology Inc | Composición farmacéutica y método para tratar o prevenir cáncer. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1844789B8 (en) | 2005-01-19 | 2014-10-08 | Sumitomo Dainippon Pharma Co., Ltd. | Emulsified composition for dilution and cancer vaccine composition |
| CA2631292C (en) * | 2005-11-30 | 2014-05-06 | International Institute Of Cancer Immunology, Inc. | Derivatised wt1 cancer antigen peptides and their use |
| KR20110117705A (ko) * | 2009-02-11 | 2011-10-27 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 톨-유사 수용체 조정제 및 질병의 치료 |
| SG11201507883SA (en) * | 2013-03-29 | 2015-10-29 | Sumitomo Dainippon Pharma Co Ltd | Wt1-antigen peptide conjugate vaccine |
| WO2014157704A1 (ja) * | 2013-03-29 | 2014-10-02 | 大日本住友製薬株式会社 | Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン |
| CN108348618B (zh) * | 2015-09-29 | 2021-06-15 | 大日本住友制药株式会社 | 腺嘌呤缀合物化合物及其作为疫苗佐剂的用途 |
| WO2018204528A1 (en) * | 2017-05-02 | 2018-11-08 | Nektar Therapeutics | Immunotherapeutic tumor treatment method |
| WO2019010560A1 (en) * | 2017-07-10 | 2019-01-17 | Immmunovaccine Technologies Inc. | PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION USING LIPID VESICLE PARTICLES OF A DEFINED SIZE, AND USES THEREOF |
| US10494370B2 (en) * | 2017-08-16 | 2019-12-03 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor |
| MX2020012674A (es) * | 2018-05-29 | 2021-02-09 | Bristol Myers Squibb Co | Porciones autoinmolantes modificadas para usarse en profarmacos y conjugados y metodos de uso y fabricacion. |
-
2020
- 2020-04-03 WO PCT/JP2020/015364 patent/WO2020204173A1/ja not_active Ceased
- 2020-04-03 CN CN202080041585.5A patent/CN113905758A/zh active Pending
- 2020-04-03 EP EP20784004.2A patent/EP3954382A4/en active Pending
- 2020-04-03 CA CA3136066A patent/CA3136066A1/en active Pending
- 2020-04-03 KR KR1020217033642A patent/KR20220004030A/ko active Pending
- 2020-04-03 US US17/600,903 patent/US20220241409A1/en active Pending
- 2020-04-03 JP JP2021512328A patent/JP7573516B2/ja active Active
- 2020-04-03 MX MX2021012200A patent/MX2021012200A/es unknown
- 2020-04-03 AU AU2020255935A patent/AU2020255935A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6849197B2 (ja) | リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用 | |
| JP6133491B2 (ja) | ジヒドロピリドピリミジン化合物 | |
| CN103497177B (zh) | 作为c‑Met抑制剂的氨基芳香杂环类化合物及其制备方法 | |
| JP2013527142A5 (https=) | ||
| AU2009292555B2 (en) | Novel prostaglandin I2 derivative | |
| WO2012102297A1 (ja) | ピラゾロピリジン誘導体、またはその薬理学的に許容される塩 | |
| FR2873694A1 (fr) | Nouveaux aza-indoles inhibiteurs de la mtp et apob | |
| JP2006508970A5 (https=) | ||
| JP2016526023A (ja) | Ｓｔａｔ６阻害剤 | |
| WO2006069525A1 (en) | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | |
| JPWO2020204173A5 (https=) | ||
| TW202233579A (zh) | 化合物、醛去氫酶2活化劑、醫藥組合物、以及治療及/或預防藥 | |
| US20030220402A1 (en) | Cancer remedy comprising anthranilic acid derivatives as active ingredients | |
| KR20120075481A (ko) | 치료적 유용성을 갖는 수용체 조절제로서 쿠마린 화합물 | |
| JPWO2020204172A5 (https=) | ||
| ES2955723T3 (es) | Nuevas piridazinas | |
| JP5574435B2 (ja) | アルキル化カテキンの効率的製造方法 | |
| JP2004509077A (ja) | カルシライティック化合物 | |
| US20260078111A1 (en) | Carbonic anhydrase enzyme inhibitors and methods of use thereof | |
| CZ20031144A3 (cs) | Kalcilytické sloučeniny | |
| EP1383511B1 (en) | Calcilytic compounds | |
| JP5302214B2 (ja) | Ｔｒｐｖ１受容体拮抗薬としてのｏ−置換ジベンジル尿素誘導体 | |
| CN114671856B (zh) | 多取代的尿嘧啶衍生物及其用途 | |
| IL276783B2 (en) | The composition and pharmaceutical compound containing it | |
| TW200403228A (en) | New anthracene derivatives and their use as pharmaceutical preparations |